Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

RIT (Ras-like without CAAX) Inhibitors

The RIT (Ras-like without CAAX) family of proteins, comprising RIT1 and RIT2, is a subgroup of the Ras superfamily of small GTPases. These proteins are unique within the Ras family due to the absence of a CAAX box at their C-terminus, which is typically involved in membrane attachment and post-translational modifications in other Ras proteins. RIT1 and RIT2 play significant roles in neuronal development, neuronal survival, and synaptic plasticity. They function as molecular switches, cycling between an active GTP-bound state and an inactive GDP-bound state, thereby regulating various downstream signaling pathways. RIT proteins are involved in the activation of key signaling cascades, including the MAPK/ERK pathway, which is crucial for cell growth, differentiation, and survival. Dysregulation of RIT signaling has been implicated in several disorders, including neurodevelopmental abnormalities and cancer, highlighting their importance in both normal cellular function and disease.

Targeting RIT (Ras-like without CAAX) proteins for disruption or inhibition using small molecules is a valuable approach for unraveling their mechanistic roles in cellular signaling. By inhibiting RIT proteins, researchers can directly observe the effects on downstream signaling pathways, such as the MAPK/ERK pathway, which is crucial for understanding their role in cell growth, differentiation, and survival. This approach enables the dissection of the RIT proteins' specific contributions to neuronal development and synaptic plasticity, areas where they are known to be particularly influential. Investigating the effects of RIT inhibition can also shed light on the mechanisms underlying various neurodevelopmental disorders and certain types of cancer, where RIT signaling is implicated.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

Since RIT proteins activate the MAPK/ERK pathway, MEK inhibitors could indirectly affect their signaling.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Raf Inhibitors could indirectly affect RIT signaling pathways, particularly in cancer cells.

Ambrisentan

177036-94-1sc-207276
5 mg
$348.00
(0)

A farnesyltransferase inhibitor, which, while not specifically targeting RIT proteins, affects prenylation, a post-translational modification important in the function of many small GTPases.

SCH772984

942183-80-4sc-473205
5 mg
$370.00
5
(0)

As RIT proteins can activate ERK, inhibiting this pathway might indirectly affect RIT function.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$117.00
$423.00
11
(1)

B-Raf inhibitors might have an indirect impact on RIT protein signaling in certain contexts.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$137.00
$512.00
7
(1)

Cdc42/Rac1 GTPase inhibitors could potentially affect signaling pathways related to RIT proteins.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK Inhibitors could indirectly influence pathways associated with RIT proteins, especially in stress responses and apoptosis.